Flagship Pioneering: Cellarity Announces the Expansion of Its Partnership With Novo Nordisk to Discover and Develop Novel Treatment in Metabolic Steatohepatitis (MASH) Using Its Innovative Platform
January 05, 2024
January 05, 2024
SOMERVILLE, Massachusetts, Jan. 5 -- Flagship Pioneering, a bioplatform innovation company, issued the following news release on Jan. 4, 2024:
Cellarity Inc., a life sciences company founded by Flagship Pioneering to transform the way medicines are created, announced today the expansion of its collaboration with Novo Nordisk A/S. The research collaboration will further leverage Novo Nordisk's expertise in metabolic disease and Cellarity's proprietary platform technology to . . .
Cellarity Inc., a life sciences company founded by Flagship Pioneering to transform the way medicines are created, announced today the expansion of its collaboration with Novo Nordisk A/S. The research collaboration will further leverage Novo Nordisk's expertise in metabolic disease and Cellarity's proprietary platform technology to . . .